Historique
Bulletin de Périodique
Addiction , Vol.118, n°12 - December 2023
Paru le :
01/12/2023
Année
2023
Page(s) :
2245-2486
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- The ChatGPT therapist will see you now: Navigating generative artificial intelligence's potential in addiction medicine research and patient care [Editorial]. Tate S., Fouladvand S., Chen J.H., Chen C.A., p. 2249-2251.
- The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review. Allaf S., Lim J.S., Buckley N.A., Cairns R., p. 2252-2274.
- Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency. Skumlien M., Craft S., p. 2275-2276.
- Measuring craving: A systematic review and mapping of assessment instruments. What about sexual craving? Miele C., Cabé J., Cabé N., Bertsch I., Brousse G., Pereira B., et al., p. 2277-2314.
- Is sexual craving a sign of sex addiction? Franken I.H.A., p. 2315-2316.
- The interaction of e-cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States. Harlow A.F., Han D.H., Eckel S.P., McConnell R., Leventhal A.M., Barrington-Trimis J.L., p. 2317-2326.
- Impact of health warning labels and calorie labels on selection and purchasing of alcoholic and non-alcoholic drinks: A randomized controlled trial. Clarke N., Ferrar J., Pechey E., Ventsel M., Pilling M.A., Munafo M.R., et al., p. 2327-2341.
- Brief, cognitive-behavioral intervention to promote treatment seeking in adults with severe alcohol use disorder: A randomized controlled trial. Conner K.R., Maisto S.A., Abar B., Szafranski S., Chiang A., Hutchison M., et al., p. 2342-2351.
- Mortality and alcohol-related morbidity in patients with delirium tremens, alcohol withdrawal state or alcohol dependence in Norway: A register-based prospective cohort study. Bramness J.G., Heiberg I.H., Hoye A., Rossow I., p. 2352-2359.
- Can counter-advertising dilute marketing effects of alcohol sponsorship of elite sport: A field experiment. Dixon H., Scully M., Niederdeppe J., Brennan E., O'Brien K., Vandenberg B., et al., p. 2360-2373.
- Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records. Domzaridou E., Carr M.J., Millar T., Webb R.T., Ashcroft D.M., p. 2374-2383.
- Independent and combined effects of methamphetamine use disorders and APOE?4 allele on cognitive performance and brain morphometry. Wang H.A., Liang H.J., Ernst T.M., Nakama H., Cunningham E., Chang L., p. 2384-2396.
- Neurophysiological error processing and addiction self-awareness correlates of reduced insight in cannabis use disorder. Macatee R.J., Schermitzler B.S., Minieri J.B., Moeller S.J., Afshar K., Preston T.J., p. 2397-2412.
- Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA. Zang X., Walley A.Y., Chatterjee A., Kimmel S.D., Morgan J.R., Murphy S.M., et al., p. 2413-2423.
- Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial. Lim A.G., Aas C.F., Çaglar E.S., Vold J.H., Fadnes L.T., Vickerman P., et al., p. 2424-2439.
- Association between substance-induced psychosis and suicide attempt: A Danish nation-wide register-based study. Munch S.D., Madsen T., Nordentoft M., Erlangsen A., Hjorthoj C., p. 2440-2448.
- Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021. Keyes K.M., Patrick M.E., p. 2449-2454.
- Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms. Morgan C.J.A., p. 2455-2456.
- Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile. Deacon R.M., Mills L., Bruno R., Mammen K., Dunlop A., Childs S., et al., p. 2457-2465.
- Estimating alcohol-attributable injury deaths: A comparison of epidemiological methods. Naimi T.S., Sherk A., Esser M.B., Zhao J., p. 2466-2476.
- Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021. Friedman J., Shover C.L., p. 2477-2485.
- The ChatGPT therapist will see you now: Navigating generative artificial intelligence's potential in addiction medicine research and patient care [Editorial]. Tate S., Fouladvand S., Chen J.H., Chen C.A., p. 2249-2251.
- The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review. Allaf S., Lim J.S., Buckley N.A., Cairns R., p. 2252-2274.
- Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency. Skumlien M., Craft S., p. 2275-2276.
- Measuring craving: A systematic review and mapping of assessment instruments. What about sexual craving? Miele C., Cabé J., Cabé N., Bertsch I., Brousse G., Pereira B., et al., p. 2277-2314.
- Is sexual craving a sign of sex addiction? Franken I.H.A., p. 2315-2316.
- The interaction of e-cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States. Harlow A.F., Han D.H., Eckel S.P., McConnell R., Leventhal A.M., Barrington-Trimis J.L., p. 2317-2326.
- Impact of health warning labels and calorie labels on selection and purchasing of alcoholic and non-alcoholic drinks: A randomized controlled trial. Clarke N., Ferrar J., Pechey E., Ventsel M., Pilling M.A., Munafo M.R., et al., p. 2327-2341.
- Brief, cognitive-behavioral intervention to promote treatment seeking in adults with severe alcohol use disorder: A randomized controlled trial. Conner K.R., Maisto S.A., Abar B., Szafranski S., Chiang A., Hutchison M., et al., p. 2342-2351.
- Mortality and alcohol-related morbidity in patients with delirium tremens, alcohol withdrawal state or alcohol dependence in Norway: A register-based prospective cohort study. Bramness J.G., Heiberg I.H., Hoye A., Rossow I., p. 2352-2359.
- Can counter-advertising dilute marketing effects of alcohol sponsorship of elite sport: A field experiment. Dixon H., Scully M., Niederdeppe J., Brennan E., O'Brien K., Vandenberg B., et al., p. 2360-2373.
- Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records. Domzaridou E., Carr M.J., Millar T., Webb R.T., Ashcroft D.M., p. 2374-2383.
- Independent and combined effects of methamphetamine use disorders and APOE?4 allele on cognitive performance and brain morphometry. Wang H.A., Liang H.J., Ernst T.M., Nakama H., Cunningham E., Chang L., p. 2384-2396.
- Neurophysiological error processing and addiction self-awareness correlates of reduced insight in cannabis use disorder. Macatee R.J., Schermitzler B.S., Minieri J.B., Moeller S.J., Afshar K., Preston T.J., p. 2397-2412.
- Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA. Zang X., Walley A.Y., Chatterjee A., Kimmel S.D., Morgan J.R., Murphy S.M., et al., p. 2413-2423.
- Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial. Lim A.G., Aas C.F., Çaglar E.S., Vold J.H., Fadnes L.T., Vickerman P., et al., p. 2424-2439.
- Association between substance-induced psychosis and suicide attempt: A Danish nation-wide register-based study. Munch S.D., Madsen T., Nordentoft M., Erlangsen A., Hjorthoj C., p. 2440-2448.
- Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021. Keyes K.M., Patrick M.E., p. 2449-2454.
- Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms. Morgan C.J.A., p. 2455-2456.
- Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile. Deacon R.M., Mills L., Bruno R., Mammen K., Dunlop A., Childs S., et al., p. 2457-2465.
- Estimating alcohol-attributable injury deaths: A comparison of epidemiological methods. Naimi T.S., Sherk A., Esser M.B., Zhao J., p. 2466-2476.
- Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021. Friedman J., Shover C.L., p. 2477-2485.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
N. CLARKE ;
J. FERRAR ;
E. PECHEY ;
M. VENTSEL ;
M. A. PILLING ;
M. R. MUNAFO ;
T. M. MARTEAU ;
G. J. HOLLANDS
|
2023
Dans Addiction (Vol.118, n°12, December 2023) Article : Périodique
Dans Addiction (Vol.118, n°12, December 2023) Article : Périodique
AIMS: To estimate the impact on selection and actual purchasing of (a) health warning labels (text-only and image-and-text) on alcoholic drinks and (b) calorie labels on alcoholic and non-alcoholic drinks.
DESIGN: Parallel-groups randomised con[...]
